| 1 |
Dermatological manifestations in diabetes mellitus |
|
| | Sunil Kumar,Roby Bose | | | IP Indian Journal of Clinical and Experimental Dermatology. 2020; 6(2): 136 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
The effect of peptide tyrosine tyrosine (PYY3–36), a selective Y2 receptor agonist on streptozotocin-induced diabetes in albino rats |
|
| | Heba A. Abdel-Hamid,Mona M. I. Abdalla,Nagwa M. Zenhom,Rasha F. Ahmed | | | Endocrine Regulations. 2019; 53(1): 26 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
CUTANEOUS INFECTIONS IN TYPE II DIABETES MELLITUS |
|
| | Shashikant Balkrishna Dhumale | | | Journal of Evidence Based Medicine and Healthcare. 2018; 5(19): 1507 | | | [Pubmed] [Google Scholar] [DOI] | |
|
